<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Merck Wants To Develop Follow-On Biologics</title>
	<atom:link href="http://www.pharmalot.com/2008/12/merck-wants-to-develop-follow-on-biologics/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmalot.com/2008/12/merck-wants-to-develop-follow-on-biologics/</link>
	<description>News, Comment and Conversation</description>
	<pubDate>Fri, 10 Feb 2012 20:28:27 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.2</generator>
		<item>
		<title>By: Michael</title>
		<link>http://www.pharmalot.com/2008/12/merck-wants-to-develop-follow-on-biologics/#comment-384121</link>
		<dc:creator>Michael</dc:creator>
		<pubDate>Tue, 09 Dec 2008 18:32:56 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=18387#comment-384121</guid>
		<description>Glyco-engineering or no, this is a great strategy for large pharma to build up expertise in biologic development.  It's an area where Merck, et. al, can compete with Teva, et. al., without cannibalizing their own core business.</description>
		<content:encoded><![CDATA[<p>Glyco-engineering or no, this is a great strategy for large pharma to build up expertise in biologic development.  It&#8217;s an area where Merck, et. al, can compete with Teva, et. al., without cannibalizing their own core business.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: pharmavet</title>
		<link>http://www.pharmalot.com/2008/12/merck-wants-to-develop-follow-on-biologics/#comment-384119</link>
		<dc:creator>pharmavet</dc:creator>
		<pubDate>Tue, 09 Dec 2008 18:16:28 +0000</pubDate>
		<guid isPermaLink="false">http://www.pharmalot.com/?p=18387#comment-384119</guid>
		<description>If you think that glyco-engineering is a winning strategy, read the history of Neose Technologies, wich is in the process of liquidating its assets.</description>
		<content:encoded><![CDATA[<p>If you think that glyco-engineering is a winning strategy, read the history of Neose Technologies, wich is in the process of liquidating its assets.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.147 seconds -->

